
==== Front
Front Oncol
Front Oncol
Front. Oncol.
Frontiers in Oncology
2234-943X
Frontiers Media S.A.

10.3389/fonc.2024.1475049
Oncology
Retraction
Retraction: LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT
Frontiers Editorial Office *

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
27 8 2024
2024
27 8 2024
14 147504902 8 2024
13 8 2024
Copyright © 2024 Frontiers Editorial Office
2024
Frontiers Editorial Office
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Retraction of the Original Research Article LOXL2 upregulation in gliomas drives tumorigenicity by activating autophagy to promote TMZ resistance and trigger EMT By Zhang Q, Yang L, Guan G, Cheng P, Cheng W and Wu A (2020). Front. Oncol. 10:569584. doi: 10.3389/fonc.2020.569584 section-in-acceptanceNeuro-Oncology and Neurosurgical Oncology
==== Body
pmcThe journal retracts the 29th October 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors requested retraction due to the image integrity concerns, which was then investigated and conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors agreed with the retraction.
